Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Wave Life Sciences Ltd. is a clinical-stage biotechnology company focused on RNA medicines to improve human health [1][3] - The company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 [1] Company Overview - Wave Life Sciences utilizes its PRISM platform, which integrates various modalities and chemistry innovations to develop RNA medicines [3] - The company’s pipeline includes clinical programs targeting obesity, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, and Huntington's disease, along with several preclinical programs [3] - Wave Life Sciences aims to transform human health by addressing both rare and common disorders through its RNA-targeting modalities [3]